News

Edwards Lifesciences' first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat ...
A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be ...
New York City-based NYU Langone Health launched a new aortic care center, led by Medical Director Geraldine Ong, MD, and Mark Peterson, MD, PhD, a cardiothoracic surgeon and professor in the ...
Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.
The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.
Abdominal aortic aneurysm (AAA) repair has undergone a remarkable transformation over the last 2 decades, primarily driven by ...
Compared with usual care, a system of electronic provider notification more often enabled patients diagnosed with severe ...